• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameCHORUS RM MODEL 7034 DDDR PACEMAKER INCL. OPUS RM MODEL 4534 SSIR PACEMAKER
Classification Nameimplantable pacemaker pulse-generator
Generic Namepulse generator, pacemaker
Regulation Number870.3610
ApplicantSORIN GROUP- CRM
PMA NumberP950029
Date Received08/02/1995
Decision Date03/10/1997
Product Code
DXY[ Registered Establishments with DXY ]
Docket Number 97M-0185
Notice Date 05/19/1997
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Recalls CDRH Recalls
Approval Order Statement 
Approval for the chorus rm model 7034 dddr pacemaker system and opus rm model 4534 ssir pacemaker system which includes an ibm compatible microcomputer which has been configured and furnished by ela medical, inc. With cso 2. 46 programming software and is connected to a cpr1 programming head. These devices are indicated for: rate adaptive pacing in patients who may benefit from increased pacing rates concurrent with increases in minute ventilation; and the generally accepted patient conditions warranting chronic cardiac pacing which include: *symptomatic paroxysmal or permanent second or third-degreee av block; *symptomatic bilateral bundle branch block; *symptomatic paroxysmal or transient sinus node dysfunctions with or without associated av conduction disorders; *bradycardia-tachycardia syndrome to prevent symptomatic bradycardia or some forms of symptomatic tachyarrhythmias; and *vaso-vagal syndromes or hypersensitive carotid sinus syndromes. The chrous rm is also indicated for dual-chamber and atrial tracking modes in patients who may benefit from maintenance of av synchrony. Dual-chamber modes are specifically indicated for treatment of conduction disorders that require restoration of both rate and av synchrony which include: *various degrees of av block to maintain the atrial contribution to cardiac output; and *vvi intolerance (e. G. , pacemaker syndrome) in the presence of persistent sinus rhythm.
Supplements: S001 S002 S003 S005 S006 S007 S008 S009 S010 
S011 S012 S013 S014 S015 S016 S017 S019 S020 
S021 S022 S023 S024 S025 S026 S027 S028 S029 
S030 S031 S032 S033 S034 S036 S037 S038 S039 
S040 S041 S042 S043 S044 S045 S046 S047 S048 
S049 S050 S051 S052 S053 S054 S055 S056 S057 
S058 S060 S061 S062 S064 S065 S066 S067 S068 
S069 S070 S071 S072 S073 S074 S075 S076 S077 
S078 S079 S080 S082 S083 S084 S085 S086 S087 
S088 S089 S090 S091 S092 S093 S094 S095 S097 
-
-